Details for New Drug Application (NDA): 062517
✉ Email this page to a colleague
The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for 062517
Tradename: | NYSTATIN |
Applicant: | Fougera Pharms Inc |
Ingredient: | nystatin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 062517
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 100,000 UNITS/ML | ||||
Approval Date: | Jun 7, 1984 | TE: | AA | RLD: | No |
Complete Access Available with Subscription